Iovance Biotherapeutics Inc (IOVA)
8.24
+0.10
(+1.23%)
USD |
NASDAQ |
Nov 21, 16:00
8.20
-0.04
(-0.49%)
After-Hours: 20:00
Iovance Biotherapeutics Debt to Equity Ratio: 0.0013 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0013 |
| June 30, 2024 | 0.0013 |
| March 31, 2024 | 0.0015 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.0017 |
| September 30, 2023 | 0.0015 |
| June 30, 2023 | 0.0017 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0013
Minimum
Jun 2024
0.0017
Maximum
Jun 2023
0.0015
Average
0.0015
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.7605 |
| Myomo Inc | 0.00 |
| Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 991.12M |
| Total Liabilities (Quarterly) | 217.66M |
| Shareholders Equity (Quarterly) | 773.46M |
| Current Ratio | 4.223 |